drugset / Trial / NCT02308098

To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product

NCT02308098 ↗

Phase 3 Completed 72 enrolled Orion Corporation, Orion Pharma
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to confirm equivalent bronchodilator efficacy of the test product compared to the reference product.

Timeline

Start
2014-12
Primary completion
2015-06
Completion
2015-06

Outcome

Met primary endpoint

paper their 95% confidence intervals (CIs) (-0.047 to 0.073 and -0.087 to 0.032, respectively) fell within the range of a clinically non-relevant difference. PMID 27817813 ↗

paper The results confirm equivalent bronchodilator efficacy of Budesonide/formoterol Easyhaler compared to Symbicort Turbuhaler. PMID 27817813 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide/formoterol Unknown 320 ug Inhaled
Subject Budesonide/formoterol Unknown 1280 ug Inhaled

Indications